These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 11847009

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
    Young JC, Lin K, Hansteen G, Travis M, Murray LJ, Jaing L, Scollay R, Hill BL.
    Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human umbilical vein endothelial cells increase ex vivo expansion of human CD34(+) PBPC through IL-6 secretion.
    Li N, Eljaafari A, Bensoussan D, Wang Y, Latger-Cannard V, Serrurier B, Boura C, Kennel A, Stoltz J, Feugier P.
    Cytotherapy; 2006 Jun; 8(4):335-42. PubMed ID: 16923609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Jun; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 13. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM.
    Stem Cells; 1997 Jun; 15(1):18-32. PubMed ID: 9007219
    [Abstract] [Full Text] [Related]

  • 14. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE.
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [Abstract] [Full Text] [Related]

  • 15. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T, Wang J, Minamiguchi H, Fujiki H, Harada S, Okuda K, Kaneko H, Yokota S, Yasukawa K, Abe T, Sonoda Y.
    Stem Cells; 2000 Nov; 18(6):444-52. PubMed ID: 11072033
    [Abstract] [Full Text] [Related]

  • 16. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E, Azzarello G, Valenti MT, Capuzzo GM, Pappagallo GL, Pilotti I, Ausoni S, Bari M, Rosetti F, Sartori D, Ciappa A, Porcellini A, Vinante O.
    Stem Cells; 2003 Nov; 21(1):33-40. PubMed ID: 12529549
    [Abstract] [Full Text] [Related]

  • 17. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.
    Andrade PZ, dos Santos F, Almeida-Porada G, da Silva CL, S Cabral JM.
    Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ, Okamoto Y, Ito M, Takaue Y, Kawano Y, Watanabe T, Yamaue T, Tohda Y, Ogose T, Shimada T, Shimosaka A, Kuroda Y.
    Stem Cells; 1997 Jul; 15(5):347-52. PubMed ID: 9323796
    [Abstract] [Full Text] [Related]

  • 19. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.
    Salmon P, Arrighi JF, Piguet V, Chapuis B, Zubler RH, Trono D, Kindler V.
    J Gene Med; 2001 Jul; 3(4):311-20. PubMed ID: 11529660
    [Abstract] [Full Text] [Related]

  • 20. Effect of addition of FLT-3 ligand and megakaryocyte growth and development factor on hemopoietic cells in serum-free conditions.
    Rossi B, Zanolin E, Vincenzi C, Diani F, Pizzolo G, de Wynter E, Nadali G.
    Stem Cells Dev; 2004 Aug; 13(4):362-71. PubMed ID: 15345130
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.